Doyle Anthony

Average Profitability
77.54%
Insider Buys Quantity
3
Insider Buys Sum
$1.08M
Insider Sells Quantity
1
Insider Sells Sum
$62,130.00

Insider Activity of Doyle Anthony

According to the SEC Form 4 filings, Doyle Anthony, being in a position of

  1. Chief Financial Officer at BioCryst Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 36300 shares for $202,191, and sold 0 shares,
    over all time since 2020-08-11, has bought 179558 shares for $1.08M, and sold 5700 shares for $62,130.

The largest purchase of all time was on 2020-08-11 and amounted to 108000 shares of BioCryst Pharmaceuticals, Inc. for $440,640.

The largest sale of all time was on 2022-12-15 and amounted to 5700 shares of BioCryst Pharmaceuticals, Inc. for $62,130.

Biography of Doyle Anthony

No biography is available at this moment.

2024-05-14PurchaseBioCryst Pharmaceuticals, Inc.
BCRX
Chief Financial Officer
36,300
0.0183%
$5.57$202,191+40%
2022-12-15SaleBioCryst Pharmaceuticals, Inc.
BCRX
Chief Financial Officer
5,700
0.0032%
$10.90$62,130-30.48%
2021-11-23PurchaseBioCryst Pharmaceuticals, Inc.
BCRX
Chief Financial Officer
35,258
0.0196%
$12.48$440,020+6.47%
2020-08-11PurchaseBioCryst Pharmaceuticals, Inc.
BCRX
Chief Financial Officer
108,000
0.063%
$4.08$440,640+148.61%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.